Teva Women's Health, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Teva Women's Health, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $36.14 per unit. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$36.1443
$24.09 – $48.14
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Methotrexate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Folate Analog Metabolic Inhibitor therapeutic class
Review the broader class where Teva Women's Health, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Teva Women's Health, Inc. make?
Teva Women's Health, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Teva Women's Health, Inc. drugs?
The average NADAC across Teva Women's Health, Inc.'s portfolio is $36.1443 per unit, ranging from $24.0884 to $48.1353.
What types of drugs does Teva Women's Health, Inc. make?
Teva Women's Health, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Folate Analog Metabolic Inhibitor (3).
Has Teva Women's Health, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Teva Women's Health, Inc. in the openFDA feed.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TREXALL 10 MG TABLET Methotrexate | $48.1352 per EA | — |
TREXALL 7.5 MG TABLET Methotrexate | $36.2091 per EA | — |
TREXALL 5 MG TABLET Methotrexate | $24.0884 per EA | — |